Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
|
ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS |
Relapsing Remitting Multiple Sclerosis (RRMS) | Phase4 | Canada | NCT06733922 |
|
A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study |
Metastatic Castration-Resistant Prostate Cancer | Phase1 |
Germany Netherlands Spain Switzerland United Kingdom United States View All
|
NCT06531499 |
|
Phase 2 Study of Rapcabtagene Autoleucel in Myositis |
Idiopathic Inflammatory Myopathies | Phase2 |
France Germany Israel Italy Japan Singapore Spain Taiwan United States View All
|
NCT06665256 |
|
Specified Drug-use Surveillance of Fabhalta Capsules |
Paroxysmal Nocturnal Hemoglobinuria | Japan | NCT06606314 | |
|
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) |
Healthy Volunteers, Pulmonary Arterial Hypertension | Phase1, Phase2 | United States | NCT06649110 |
|
An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE). |
Systemic Lupus Erythematosus, SLE | Phase1 |
Bulgaria China Germany Netherlands Spain Switzerland View All
|
NCT06335979 |
|
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE) |
Sickle Cell Disease | Phase3 |
Colombia United States |
NCT06439082 |
|
A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS) |
Amyotrophic Lateral Sclerosis (ALS) | Phase2 |
Australia Belgium Canada China Denmark France Germany Ireland Japan Netherlands Poland South Korea Spain Sweden Switzerland United Kingdom United States View All
|
NCT06643481 |
|
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA) |
Spinal Muscular Atrophy (SMA) |
Greece Ireland Israel Poland Portugal Romania Russia South Korea Taiwan United States View All
|
NCT04174157 | |
|
Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy |
Atypical Hemolytic Uremic Syndrome | Phase3 |
Austria Brazil China Czechia Greece India Japan Slovakia Slovenia South Korea Taiwan United Kingdom United States View All
|
NCT04889430 |